iShares US Pharmaceuticals ETF
IHE
IHE
82 hedge funds and large institutions have $147M invested in iShares US Pharmaceuticals ETF in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 34 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 34
100% less call options, than puts
Call options by funds: $1K | Put options by funds: $348K
Holders
82
Holding in Top 10
–
Calls
$1K
Puts
$348K
Top Buyers
| 1 | +$55.9M | |
| 2 | +$3.82M | |
| 3 | +$3.38M | |
| 4 |
Fisher Asset Management
Camas,
Washington
|
+$216K |
| 5 |
Wolverine Trading
Chicago,
Illinois
|
+$214K |
Top Sellers
| 1 | -$6.03M | |
| 2 | -$5.99M | |
| 3 | -$1.57M | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$1.02M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$985K |